sars-cov-2 rbd fusion protein recombinant virus protein (strain lp.8.1- lp.8.1)

Italy

Drugs containing this active substance

  • BIMERVAX LP.8.1

    It is a vaccine used to prevent COVID-19, the disease caused by the SARS-CoV-2 virus.

    Form: emulsion, injectable

    Active substance Dosage
    sars-cov-2 rbd fusion protein recombinant virus protein (strain lp.8.1- lp.8.1) -

    ATC: J07BN04

    Manufacturer: hipra human health, s.l.u.